Castleman's disease is a rare lymphoproliferative disorder characterized by an abnormal growth of lymphoid tissue. It encompasses several forms, including unicentric Castleman disease (UCD ...

The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...

Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.

Atara Biotherapeutics Inc. received a complete response letter (CRL) from the U.S. FDA for its lead product, Ebvallo ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...

The FDA has said it cannot approve tabelecleucel to treat patients 2 years of age and older who have EBV-positive PTLD and have received at least 1 prior therapy.

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

The U.S. Food and Drug Administration on Thursday declined to approve Atara Biotherapeutics' cancer therapy, chemically ...

Halsey is reflecting on their two year transformation following their health diagnosis. "Hey. I just wanna say; I looked and ...

The 30-year-old singer, who uses the pronouns she/they, posted a trio of images on the social media platform comparing ...